Alternatives to Dupixent
Dupixent is a HealthTech tool: a biologic medicine developed by Sanofi and Regeneron Pharmaceuticals for treating various inflammatory conditions. Here are the 60 closest alternatives, compared on pricing, features and what real users say.
The 20 closest HealthTech companies to Dupixent
- Website
AbbVie9BiotechnologyNorth Chicago, United StatesA global research-based biopharmaceutical company focused on developing advanced therapies for complex medical conditions.
- Website
PHIL64HealthTechScottsdale, USA$102.5MEnabling pharmaceutical companies to deliver medications directly to patients at scale.
- Website PEPear Therapeutics49HealthTechBoston, United States$409.0M
Pioneered prescription digital therapeutics for serious diseases, integrating software with pharmaceuticals.
- Website
Mochi Health47HealthTechSan Francisco, United States$1.2MTelehealth platform offering personalized treatment plans for weight care, wellness, skin, hair, mental health, and more.
- Website
CurifyLabs41HealthTechHelsinki, Finland$12.0MAutomating pharmaceutical compounding for personalized medicine.
- Website
Infinimmune60BiotechnologyAlameda, United States$75.0MDeveloping human-derived antibodies for inflammatory diseases and cancer using AI and proprietary platforms.
- Website
Komodo40HealthTechSan Francisco, United States$344.0MKomodo Health provides a healthcare intelligence platform that uses real-world data to improve patient care and reduce disease burden.
- Website
KaliVir Immunotherapeutics, Inc.57BiotechnologyPittsburgh, United States$14.0MClinical-stage biotechnology company developing multi-mechanistic oncolytic immunotherapy programs for cancer treatment.
- Website
Janux Therapeutics57BiotechnologySan Diego, USA$181.0MA clinical-stage biopharmaceutical company developing novel immunotherapies.
- Website
Alector55BiotechSouth San Francisco, United States$162.5MBiotechnology company developing immuno-neurology therapies for neurodegenerative diseases.
- Website KHKhartis Therapeutics, Inc.53BiotechnologySan Diego, United States$50.0M
Developing oral small molecule medicines for immunological and chronic diseases.
- Website
Immix Biopharma, Inc.51BiotechnologyLos Angeles, United States$5.0MA clinical-stage biopharmaceutical company developing novel cell therapies for AL Amyloidosis and other serious diseases.
- Website
argenx49BiTechAmsterdam, Netherlands$51.1MGlobal immunology company developing antibody-based therapies for severe autoimmune diseases.
- EXExcalipoint Therapeutics39BiotechnologyShanghai, China$68.7M
Developing next-generation T-cell engager therapies for cancer and autoimmune diseases.
- Website
Medidata44HealthTechNew York, United StatesCloud-based platform for clinical trial data management and analytics.
- Website
Moderna77BiotechnologyCambridge, United States$4.5BModerna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.
- Website
Runway AI70Generative AINew York, United States$358.5MRunway AI is a generative AI research company creating tools for video, image, and multimedia content generation.
- Website
Schrödinger69Drug DiscoveryNew York, United States$220.0MPhysics-based software platform for molecular discovery and design in life and materials sciences.
- Website
Immunai69HealthcareNew York, United States$295.0MMapping and reprogramming the immune system with single-cell biology and AI for therapeutic discovery.
- Website
Adaptive Biotechnologies69BiotechSeattle, United States$300.0MLeveraging the adaptive immune system to diagnose and treat disease.
Showing the 20 closest matches. See the rest on the Dupixent profile.
Compare Dupixent head to head
Side by side on what each one does, what it costs, and what real users report.